Abstract
Context Hypothalamus-pituitary-gonadal (HPG)-axis disturbances are a common phenomenon in patients with classic congenital adrenal hyperplasia (CAH). 11-oxygenated androgens have been suggested to play a role in this context.
Design Cross-sectional single center study including 89 patients (N=42 men, N=55 women) with classic CAH.
Main Outcome Measures Independent predictors for hypogonadism in men and secondary amenorrhea in women with CAH with a special focus on 11-ketotestosterone (11KT) and 11β-hydroxyandrostenedione (11OHA4).
Results Hypogonadotropic hypogonadism was present in 23% of men and 61% of those women currently not on contraceptives suffered from irregular menstrual cycles or amenorrhea. Testicular adrenal rest tumor (TART) was documented in 28% of men. While 11KT (3.5x) and 11OHA4 (5.7x) among other adrenal steroids were significantly elevated in men with hypogonadism, in stepwise logistic regression, the only significant independent predictor for hypogonadism were elevated 17-OHP levels (B = 0.006; p = 0.039). Although 11KT (5.2x) and 11OHA4 (3.7x) levels were also significantly higher in women with amenorrhea in comparison to those with a regular cycle, the only significant predictor for amenorrhea were elevated total testosterone levels (B = 1.806; p = 0.040). 11-oxygenated androgens were not different in those with TART and those without. Of note, there were no significant differences in 11OHA4 or 11KT between those with a regular cycle and those currently on hormonal contraceptives.
Conclusions 11-oxygenated androgens do not seem to add additional information for explaining menstrual disturbances and hypogonadism in patients with CAH in comparison to established marker of disease control.
Highlights
The 11-oxygenated androgens 11-ketotestosterone and 11β-hydroxyandrostenedione are significantly elevated in men with CAH with hypogonadotropic hypogonadism and women with amenorrhea.
Elevated 17-OHP levels in male patients and elevated testosterone levels in female patients are however the dominant predictor of HPG-axis disturbances.
11-oxygenated androgens are not predictive for testicular adrenal rest tumors in men with CAH
11-ketotestosterone and 11β-hydroxyandrostenedione levels do not seem to be influenced by intake of oral contraceptives.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the IFCAH grant 2013 to NR and by the Deutsche Forschungsgemeinschaft (Heisenberg Professorship 325768017 to NR and Projektnummer: 314061271-TRR205 to NR). The authors declare no competing interests.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical review board of the Ludwig-Maximilian-Universitaet
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of interest All authors have declared that no conflict of interest exists
Data Availability
Data is can be provided by the corresponding author on reasonable request
Abbreviations
- 11KT
- 11-ketotestosterone
- 11OHA4
- 11β-hydroxyandrostenedione
- 17-OHP
- 17α-hydroxyprogesterone
- ACTH
- Adrenocorticotropic hormone
- AR
- Androgen receptor
- CAH
- Congenital adrenal hyperplasia
- CPA
- Cyproterone acetate
- DHEAS
- Dehydroepiandrosterone sulfate
- ER
- Estrogen receptor
- FC
- Fludrocortisone
- FSH
- Follicle-stimulating hormone
- GC
- Glucocorticoid(s)
- GnRH
- Gonadotropin releasing hormone
- HC
- Hydrocortisone
- HPG
- Hypothalamus-pituitary-gonadal
- LH
- Luteinizing hormone
- PR
- Progesterone receptor
- SERM
- Selective estrogen receptor modulator
- SHBG
- Sex hormone binding globulin
- SV
- Simply virilizing
- SW
- Salt-wasting
- TART
- Testicular adrenal rest tumor